Expert Review of Anticancer Therapy

News in Brief
pp. 507-510(4)

News in Brief
pp. 507-510(4)

Therapeutic options and treatment of muscle invasive bladder cancer
pp. 511-522(12)
Authors: O'Connor, R Corey; Alsikafi, Nejd F; Steinberg, Gary D

Photodynamic therapy for superficial bladder cancer
pp. 523-530(8)
Authors: Shackley, David C; Briggs, Catherine; Whitehurst, Colin; Betts, Christopher D; O'Flynn, Kieran J; Clarke, Noel W; Moore, James V

Gene therapy for superficial bladder cancer
pp. 531-540(10)
Authors: Rosser, Charles J; Benedict, William F; Dinney, Colin PN

Retinoids in the prevention of bladder cancer
pp. 541-545(5)
Authors: Nutting, Christopher M; Huddart, Robert A

New agents for the treatment of renal cell carcinoma
pp. 546-554(9)
Authors: Tian, Gary G; Dawson, Nancy A

Wilms tumor: progress to date and future considerations
pp. 555-564(10)
Author: Ehrlich, Peter F

Prognostic factors and molecular markers for renal cell carcinoma
pp. 565-575(11)
Authors: Bui, Matthew H; Zisman, Amnon; Pantuck, Allan J; Han, Ken-ryu; Wieder, Jeff; Belldegrun, Arie S

Evolving classification of renal cell neoplasia
pp. 576-584(9)
Authors: Delahunt, Brett; Velickovic, Marija; Grebe, Stefan KG

Molecular and pharmacological strategies to overcome multidrug resistance
pp. 585-594(10)
Authors: Shabbits, Jennifer A; Krishna, Rajesh; Mayer, Lawrence D

Genetic alterations and chemotherapeutic response in human diffuse gliomas
pp. 595-605(11)
Authors: Kitange, Gaspar J; Smith, Justin S; Jenkins, Robert B